Changing Patterns of Undiagnosed HIV Infection in the Netherlands: Who Benefits Most from Intensified HIV Test and Treat Policies?

• Eline L. M. Op de Coul ,

  Contributed equally to this work with: Eline L. M. Op de Coul, Imke Schreuder

  Affiliation Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Imke Schreuder ,

  Contributed equally to this work with: Eline L. M. Op de Coul, Imke Schreuder

  Affiliations Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands, Department of ViroScience, Erasmus Medical Centre, Rotterdam, the Netherlands

  ⨯
• Stefano Conti,

  Affiliation Statistics, Modelling and Economics Department, Public Health England, London, United Kingdom

  ⨯
• Ard van Sighem,

  Affiliation Stichting HIV Monitoring, Amsterdam, The Netherlands

  ⨯
• Maria Xiridou,

  Affiliation Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Maaike G. Van Veen,

  Affiliation Cluster Infectious Diseases, STI clinic department, Amsterdam Health Service, Amsterdam, the Netherlands

  ⨯
• Janneke C. M. Heijne

  * E-mail: janneke.heijne@rivm.nl

  Affiliation Centre for Infectious Diseases Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯